Does heavy alcohol use impair folate absorption and raise homocysteine levels?

Heavy alcohol use has profound implications for cellular nutrition, specifically targeting the absorption, transport, and utilization of folate, which ultimately leads to a metabolic backlog manifested as elevated homocysteine.

Clinical and metabolic impacts

• Impaired folate absorption: Chronic alcohol consumption down-regulates the expression of the intestinal proton-coupled folate transporter (PCFT) and the reduced folate carrier (RFC) at the apical brush-border membrane, severely reducing the body's capacity to absorb dietary folate.
• Hepatic and systemic disruption: Alcohol compromises hepatic folate uptake, limits conversion to its active tetrahydrofolate (THF) forms, and impairs enterohepatic circulation, leading to rapid systemic depletion.
• Hyperhomocysteinemia: This depletion, combined with the direct inhibition of the remethylation pathway, leads to significantly elevated plasma homocysteine levels (hyperhomocysteinemia), which is a established risk factor for cardiovascular and neurocognitive complications.

Mechanistic pathways

• Transporter downregulation: Ethanol exposure decreases the gene and protein expression of PCFT and RFC, disrupting their localization in membrane lipid rafts and altering intracellular kinase signaling.
• Enzymatic block: Ethanol and its highly reactive metabolite, acetaldehyde, directly inhibit methionine synthase (a vitamin B12-dependent enzyme). This blocks the clearance of homocysteine, causing it to accumulate in the plasma, while also reducing the S-adenosylmethionine (SAM) to S-adenosylhomocysteine (SAH) ratio, which impairs critical DNA methylation pathways.

Bottom line

• Heavy alcohol use impairs folate absorption by down-regulating intestinal transporters (PCFT, RFC) and directly inhibits methionine synthase, resulting in systemic folate deficiency and elevated homocysteine, which are key targets for clinical resolution through alcohol abstinence and B-vitamin supplementation.